Skip to main content

Molecular mechanisms of the activator and/or suppressive immune response:A possible key target for blocking glioblastoma progression ¿Chaperone-mediated autophagy in pericytes¿.

RYC2019-027520-I

•
Funding agency name Agencia Estatal de Investigación
Funding agency acronym AEI
Program Programa Estatal de Promoción del Talento y su Empleabilidad en I+D+i
Subprogram Subprograma Estatal de Incorporación
Call Ramón y Cajal
Call year 2019
State Plan 2017-2020 Plan Estatal de Investigación Científica y Técnica y de Innovación
Beneficiary centre UNIVERSIDAD DE MURCIA

Resultados relacionados

Resultados totales (Incluyendo duplicados): 3
Encontrada(s) 1 página(s)

DIGITAL.CSIC. Repositorio Institucional del CSIC
Publication Artículo científico (JournalArticle)

Chaperone-mediated autophagy ablation in pericytes reveals new glioblastoma prognostic markers and efficient treatment against tumor progression

  • Molina, María Luisa
  • García-Bernal, David
  • Salinas, María Dolores
  • Rubio, Gonzalo
  • Aparicio, Pedro
  • Moraleda, José María
  • Martínez, Salvador
  • Valdor, Ruth
[Background]: The lack of knowledge of the progression mechanisms of glioblastoma (GB), the most aggressive brain tumor, contributes to the absence of successful therapeutic strategies. Our team has recently demonstrated a crucial new role for chaperone-mediated autophagy (CMA) in pericytes (PC)-acquired immunosuppressive function, which prevents anti-tumor immune responses and facilitates GB progression. The possible impact that GB-induced CMA in PC has on other functions that might be useful for future GB prognosis/treatment, has not been explored yet. Thus, we proposed to analyze the contribution of CMA to other GB-induced changes in PC biology and determine if CMA ablation in PC is a key target mechanism for GB treatment., [Methods]: Studies of RNA-seq and secretome analysis were done in GB-conditioned PC with and without CMA (from knockout mice for LAMP-2A) and compared to control PC. Different therapeutic strategies in a GB mouse model were compared., [Results]: We found several gene expression pathways enriched in LAMP2A-KO PC and affected by GB-induced CMA in PC that correlate with our previous findings. Phagosome formation, cellular senescence, focal adhesion and the effector function to promote anti-tumor immune responses were the most affected pathways, revealing a transcriptomic profiling of specific target functions useful for future therapies. In addition, several molecules associated with tumor mechanisms and related to tumor immune responses such as gelsolin, periostin, osteopontin, lumican and vitamin D, were identified in the PC secretome dependent on GB-induced CMA. The CMA ablation in PC with GB cells showed an expected immunogenic phenotype able to phagocyte GB cells and a key strategy to develop future therapeutic strategies against GB tumor progression. A novel intravenous therapy using exofucosylated CMA-deficient PC was efficient to make PC reach the tumor niche and facilitate tumor elimination., [Conclusion]: Our results corroborate previous findings on the impaired immunogenic function of PC with GB-induced CMA, driving to other altered PC functions and the identifications of new target markers related to the tumor immune responses and useful for GB prognosis/therapy. Our work demonstrates CMA ablation in PC as a key target mechanism to develop a successful therapy against GB progression., This work was mainly developed by SAF 2015-73923-JIN, funded by MCIN/AEI/10.13039/501100011033 and “ERDF A way of making Europe” and Seneca 20840/PI/18 funded by Seneca Foundation “Agencia de Ciencia y Tecnología de la Región de Murcia” (to RV). It was also partially supported by RYC 2019-027520-I funded by MCIN/AEI/10.13039/501100011033, as ESF Investing in your future”; PID 2020-114010RB-I00 funded by MCIN/AEI/10.13039/501100011033 (to RV), RD16/0011/0010 and RD16/0011/0001 (to SM and JMM) funded by Instituto de Salud Carlos III and co-founded by European Regional Development Funds “una manera de hacer Europa”; SAF 2017-83702 (to SM)., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publication Artículo científico (JournalArticle)

Chaperone-mediated autophagy sustains pericyte stemness necessary for brain tissue homeostasis

  • Salinas, María Dolores
  • Martínez, Carlos M.
  • Roca, Francisco J.
  • García-Bernal, David
  • Martínez-Morga, Marta
  • Rodríguez-Madoz, Juan R.
  • Prósper, Felipe
  • Zapata, Agustín
  • Moraleda, José María
  • Martínez, Salvador
  • Valdor, Ruth
The original contributions presented in the study are publicly available in ENA under accession number PRJEB48545., [Introduction] Pericytes (PCs) are mural cells exhibiting some mesenchymal stem cell (MSC) properties and contribute to tissue regeneration after injury. We have previously shown that glioblastoma cancer cells induce in PCs, a pathogenic upregulation of chaperone-mediated autophagy (CMA) which modulates immune functions and MSC-like properties to support tumor growth., [Objectives] The aim of the study was to interrogate the role of CMA-regulated MSC properties in PCs in the context of tissue repair during inflammation triggered by a demyelinating injury., [Methods] Studies of RNA-seq were done PCs with (WT) and without (LAMP-2A KO) CMA. Cell characterization related to stemness, lineage and morphology was done in WT and KO PCs. Secretome analysis and cell differentiation assay using the supernatants from CMA-efficient and deficient PCs cultures was done in mesenchymal cells. Inflammatory response of brain cells was assessed with WT and KO PCs secretome. To corroborate in vitro results, CMA modulation in response to inflammation in PCs and tissue repair markers were measured in the lesion areas of a demyelination mouse model and correlated with the tissue reparation after intravenous PC administration. An inflammatory mediator was used to study effects on PC-CMA activity., [Results] We found that inflammatory mediators such as IFNγ downregulate CMA in PCs, suppressing PC stemness and promoting a pro-inflammatory secretome. Restoration of PC CMA activity during inflammation maintains PC MSC properties and induces an MSC-like proteome which decreases inflammation and promotes tissue repair. We identified secreted proteins involved in regenerative and protective processes, and therefore, necessary to restore brain tissue homeostasis after inflammation induced by a demyelinating injury., [Conclusion] we show that manipulation of CMA activity in host PCs could be a useful therapeutical approach in the context of brain inflammation, which might be extended to other diseases where the pericyte has a key role in response to inflammation., This work was mainly developed by Seneca 20840/PI/18 funded by Seneca Foundation “Agencia de Ciencia y Tecnología de la Región de Murcia”, by Ramon y Cajal (RYC) 2019-027520-I funded by Ministerio de Ciencia, Innovación y Universidades (MCIU) and Agencia Estatal de Investigación (AEI) MCIU/AEI/10.13039/501100011033, as “ European Social Fund (ESF) Investing in your future”, and by PID2020-114010RB-I00 and PID2023-149111OB-I00 funded by MICIU/AEI/10.13039/50110001 1033 and Fondo Europeo de Desarrollo Regional (FEDER), UE (to RV). It was also partially supported by CaixaImpulse CI23-20487 funded by ¨La Caixa¨ Foundation (to RV) and by Spanish Network of Advanced Therapies (TERAV), RICORS subprogram (to AGZ, FP, SM and JMM), funded by Instituto de Salud Carlos III and co-funded by European Regional Development Fund (ERDF)-Next Generation EU “Plan de Recuperación, Transformación y Resiliencia”. FJR was supported by fellowship RYC2019-571 027799-I funded by MCIU/AEI., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publication Artículo científico (JournalArticle)

Chaperone mediated autophagy is deficient in spinal motoneurons of ALS patients with TDP-43 proteinopathy

  • Garrigós, Daniel
  • Martínez-Morga, Marta
  • Pombero, Ana
  • García López, Raquel
  • Pastor, Diego
  • Riquelme, Dolores
  • Blanquer, Miguel
  • Iniesta, Francisca
  • Valdor, Rut
  • Geijo-Barrientos, Emilio
  • Hargus, Gunnar
  • Moraleda, José María
  • Martínez, Salvador
Amyotrophic Lateral Sclerosis (ALS) is a progressive neurodegenerative disease characterized by the selective loss of motor neurons (MNs), ultimately resulting in paralysis and respiratory failure within 3 to 5 years of onset. Fewer than 10% of ALS cases are familial (fALS), while the vast majority are sporadic (sALS) with an unknown etiology. A pathological hallmark of ALS is the accumulation of misfolded TDP-43 protein aggregates within MNs. Although TDP-43 is known to be degraded via chaperone-mediated autophagy (CMA), the status of CMA activity in sALS has not been previously explored. To investigate this, we analyzed CMA in human spinal cord tissue by assessing the expression of LAMP2A, a key lysosomal receptor and marker of CMA activity. In control samples, spinal cord MNs exhibited robust LAMP2A expression. In contrast, MNs from sALS patients showed a marked reduction in LAMP2A levels, coinciding with the presence of TDP-43 pathology. Notably, analysis of LC3, a marker of macroautophagy, revealed no significant differences in expression between control and sALS MNs. Interestingly, MNs within the Onuf’s nucleus, a population known to be resistant to degeneration in ALS, retained normal LAMP2A expression and did not exhibit TDP-43 aggregation in sALS cases. These findings demonstrated that CMA is essential for the clearance of TDP-43 in spinal cord MNs and that its dysfunction may contribute to the pathogenesis of sALS. Furthermore, the high dependence of spinal cord MNs on CMA activity may underlie their selective vulnerability to degeneration when CMA is impaired, and highlight CMA enhancement as a promising therapeutic strategy to restore proteostasis and prevent MN degeneration in ALS., This work was funded by the following projects: Spanish State Research Agency, through the “Severo Ochoa” Programme for Centres of Excellence in R&D (Grant Numbers SEV-2017-0723), the Spanish Ministerio de Ciencia e Innovación grant numbers SAF2017-83702-R and PID2020-11817RB-I00 and the Generalitat Valenciana (program Prometeo II, Grant Number 2018/041). This work has been partially funded by the Instituto de Salud Carlos III (ISCIII) through the RICORS Project ‘RD21/0017/0017; RD21/0017/0001; TERAV’ supported by the Next Generation EU Program (Recovery, Transformation and Resilience Plan). RV was supported by fellowship Ramon y Cajal (RYC) 2019-027520-I funded by Ministerio de Ciencia, Innovación y Universidades (MCIU) and Agencia Estatal de Investigación (AEI) MCIU/AEI/https://doi.org/10.13039/501100011033, as “European Social Fund (ESF) Investing in your future”., With funding from the Spanish government through the "Severo Ochoa Centre of Excelence" accreditation (SEV-2017-0723), Peer reviewed